Skip to content
Human Trial for OST-HER2 episode artwork

Feb 11, 2022 1 hr

Human Trial for OST-HER2

from MIB Agents OsteoBites and osTEAo Hosted by MIB Agents Osteosarcoma

Today we talk with Dr. Damon Reed from Moffit Cancer Center and Dr. Nicola Mason from University of Pennsylvania School of Veterinary Medicine about the promising results from a multi-institutional clinical trial evaluating the safety and efficacy of a recombinant Listeria to prevent metastatic disease in dogs with osteosarcoma, and how that will translate to a human trial. #clinicaltrials #osteosarcoma #cancerupdates

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Human Trial for OST-HER2

0:00 1:00:40

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of MIB Agents OsteoBites and osTEAo?

This episode is 1 hour and 0 minutes long.

When was this MIB Agents OsteoBites and osTEAo episode published?

This episode was published on February 11, 2022.

Can I download this MIB Agents OsteoBites and osTEAo episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.